Data management in oncology clinical trials features multiple complexities, and choosing the right EDC system is essential.

Obe-cel demonstrates high remission rates in pediatric patients with high-risk r/r B-ALL with overall response rate (ORR) of 95.5%; low rates of high-grade cytokine release syndrome (CRS) and immune ...

Raymond James TMT & Consumer Conference December 8, 2025 11:20 AM ESTCompany ParticipantsPaul Shawah - Executive ...

In today’s ACT Brief, we examine how the FDA’s CNPV Program is reshaping operational planning and accelerated submission ...

The technology is designed to help thousands of diabetic and hypertensive patients achieve control over their conditions, ...

Solid Biosciences Inc. (Nasdaq: SLDB) (the 'Company” or 'Solid”), a life sciences company developing precision genetic ...

A new brain implant stands to transform human-computer interaction and expand treatment possibilities for neurological ...

Artificial intelligence-enhanced wearable devices, such as continuous glucose monitors (CGMs), have dramatically improved the ...

AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...

Merz Therapeutics to present more than 20 abstracts and posters at the TOXINS 2026 8th International Conference, taking place January 14-17 2026 in Madrid, Spain. Merz Therapeutics, a leading ...

A radically miniaturized brain implant called BISC is redefining what’s possible in human–computer interaction, offering a ...

In a major move that signals the next evolution of technology in home-based care, Forcura and Medalogix — two leaders in workflow automation and clinical intelligence — have come together under a s | ...